secwatch.observer — SEC 8-K summary
======================================

Issuer:     Envoy Medical, Inc. (COCH)
CIK:        0001840877
Form:       8-K
Filed at:   2026-02-13T23:59:59+00:00
Accession:  0001213900-26-016584
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Envoy Medical closes $30.0M public offering; milestone-linked warrants could add $48.0M
--------------------------------------------------------------------------------

- Gross proceeds $30.0M from 75M shares/pre-funded warrants at $0.40/unit; up to $48M additional if milestone warrants exercised for cash.
- Offering led by Nantahala Capital; insiders bought ~2.25M shares ($0.9M), existing shareholder Glen Taylor bought 18.75M shares ($7.5M).
- Net proceeds extend cash runway into H2 2027, beyond expected PMA submission for Acclaim CI device.
- Series A-1 warrants expire 30 days after PMA submission; Series A-2 warrants expire 30 days after FDA approval; exercise price $0.40.
- H.C. Wainwright acted as exclusive placement agent; placement agent warrants for 3.75M shares at $0.50 per share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840877/000121390026016584/0001213900-26-016584-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840877/000121390026016584/ea0276972-8k_envoy.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-016584

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer